ToBio
Latest round
- Angel
Last raised
- Jan 2025
Total raised
- $6.8M
Investors
- 2
About ToBio
Based in Wuhan, China, and founded in 2024, ToBio, Inc is a molecular diagnostics company. It has R&D centers in Boston and Shanghai. The company mainly provides diagnostic technology platforms and molecular companion diagnostic (POCT) technologies. Its polymerase chain reaction (PCR) detection equipment can complete the detection of thousands of targets within 15 to 30 minutes and issue a report. The company generates revenue by developing diagnostic technology platforms and molecular companion diagnostics (POCT) technologies. The company will use the funds for technology transformation, product development and global market expansion of medical devices.
Who invested in ToBio
2 investors across 1 round
See all investors in ToBio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Angel
Jan 11, 2025
Amount
$6.8M
Investors
Questions about ToBio
Who invested in ToBio?
ToBio has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has ToBio raised?
ToBio has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did ToBio last raise money?
ToBio's most recent round on record is a Angel, in Jan 2025.
What does ToBio do?
Based in Wuhan, China, and founded in 2024, ToBio, Inc is a molecular diagnostics company.
Where is ToBio headquartered?
ToBio is headquartered in Wuhan, China.
Which VCs invest in companies like ToBio?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back biotechnology companies at ToBio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Angel
Raising like ToBio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.